FindTrial
Sign In

Optimized Number of Specimen for Ultrasound Guided Core Needle Biopsy of Suspicious Axillary Lymph Node for Breast Cancer Patients

Optimized Number of Specimen for Ultrasound Guided Core Needle Biopsy of Suspicious Axillary Lymph Node for Breast Cancer Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800020204
Enrollment
Unknown
Registered
2018-12-20
Start date
2019-01-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Gold Standard:Pathology diagnosis
Index test:Core Needle Biopsy

Sponsors

SunYat-sen Memorial Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Sign up inform consent form; 2. Ultrasound diagnosed suspicious breast cancer(BI-RADS:4C\5) or pathology diagnosed breast cancer; 3. Suspicious metastasis axillary lymph node discovered by ultrasound; 4. Did not received any chemotherapy, endocrinotherapy, radiotherapy or axillary surgery.

Exclusion criteria

Exclusion criteria: 1. Could not perform core needle biopsy to the axillary lymph node due to certain reasons; 2. Patients who are unable to undergo core needle biopsy such as allergic to Lidocaine; 3. Patients who have coagulation dysfunction; 4. With any mental disease which affect the ability to understand the Inform Consent Form.

Design outcomes

Primary

MeasureTime frame
The pathology diagnosis of every specimen;SPE, SEN, ACC;—

Countries

China

Contacts

Public ContactGong Chang

Breast Tumor Center, Sun Yat-sen Memorial Hospital

changgong282@163.com+86 13925089353

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026